Back to Agenda
Session 9C: Regional Updates – Part 3: Middle East
Session Chair(s)
Ihab Attia
Regulatory Director
Eli Lilly and Company, United Arab Emirates
This session will provide an overview and update about the regulatory landscape in the Middle East, with main focus on challenges and opportunities. It will reflect the updated accelerated programs implemented recently in the region and sharing successful stories. It will address as well the current post-approval CMC changes model, the specificity of the local requirement linked to the complex supply management and patient access implication, with an industry proposal for future trend to optimize the life cycle maintenance activity of the registered products.
Speaker(s)
Speaker
Ihab Attia
Eli Lilly and Company, United Arab Emirates
Regulatory Director
Speaker
Inas Chehimi
Novartis Pharma Services AG, United Arab Emirates
Head RA Middle East & North Africa
Have an account?